83
Views
6
CrossRef citations to date
0
Altmetric
Review

Anakinra and related drugs targeting interleukin-1 in the treatment of cryopyrin-associated periodic syndromes

&
Pages 15-25 | Published online: 03 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Emmanuelle C. Landmann & Ulrich A. Walker. (2017) Pharmacological treatment options for cryopyrin-associated periodic syndromes. Expert Review of Clinical Pharmacology 10:8, pages 855-864.
Read now

Articles from other publishers (5)

Laura González-Cofrade, Irene Cuadrado, Ángel Amesty, Ana Estévez-Braun, Beatriz de las Heras & Sonsoles Hortelano. (2022) Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking. Pharmaceuticals 15:7, pages 825.
Crossref
Yadira Palacios & Leslie Chavez-Galan. (2022) Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative?. Pharmaceuticals 15:5, pages 616.
Crossref
N. V. Vlasenko, N. S. Churilova, Ya. V. Panasyuk, V. V. Klushkina, D. V. Dubodelov, E. N. Kudryavtseva, T. A. Semenenko, S. N. Kuzin & N. G. Akimkin. (2021) Single nucleotide polymorphisms of the interleukin-1 superfamily members: аssociation with viral hepatitis B and C. Journal of microbiology, epidemiology and immunobiology 98:2, pages 198-212.
Crossref
Sameer Agarwal, Santosh Sasane, Hardik A. Shah, Jignesh P. Pethani, Prashant Deshmukh, Vismit Vyas, Pravin Iyer, Harsh Bhavsar, Kasinath Viswanathan, Debdutta Bandyopadhyay, Poonam Giri, Jogeswar Mahapatra, Abhijit Chatterjee, Mukul R. Jain & Rajiv Sharma. (2020) Discovery of N -Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome Inhibitors . ACS Medicinal Chemistry Letters 11:4, pages 414-418.
Crossref
Kun Chi, Xiaodong Geng, Chao Liu, GuangYan Cai & Quan Hong. (2020) Research Progress on the Role of Inflammasomes in Kidney Disease. Mediators of Inflammation 2020, pages 1-9.
Crossref